CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 122 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $20,406,000 | -30.9% | 872,415 | -14.9% | 4.22% | -12.0% |
Q4 2020 | $29,514,000 | -49.1% | 1,024,800 | -64.2% | 4.79% | -8.1% |
Q3 2020 | $57,983,000 | -44.6% | 2,861,924 | -17.8% | 5.22% | -37.6% |
Q2 2020 | $104,574,000 | +68.3% | 3,480,000 | +76.0% | 8.36% | +28.7% |
Q1 2020 | $62,153,000 | +16.2% | 1,977,502 | +74.2% | 6.49% | +39.5% |
Q4 2019 | $53,476,000 | – | 1,135,122 | – | 4.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |